145 related articles for article (PubMed ID: 6345751)
1. Antidiabetic behavior of biguanides.
Vicente-Pedrós F; Trejueque Monge J; Tomás Vert F
J Pharm Sci; 1983 May; 72(5):565-7. PubMed ID: 6345751
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents.
Sweeney D; Raymer ML; Lockwood TD
Biochem Pharmacol; 2003 Aug; 66(4):663-77. PubMed ID: 12906931
[TBL] [Abstract][Full Text] [Related]
3. [Differences between 2 antidiabetic biguanides: metformin and phenformin].
Journ Annu Diabetol Hotel Dieu; 1972; 13(0):332-9. PubMed ID: 4605621
[No Abstract] [Full Text] [Related]
4. Gas chromatographic behavior of buformin hydrochloride, phenformin hydrochloride and phenylbiguanide. The pyrolytic formation of substituted 2,4,6-triamino-1,3,5-triazines from biguanides.
Wickramasinghe JA; Shaw SR
J Chromatogr; 1972 Sep; 71(2):265-73. PubMed ID: 5057114
[No Abstract] [Full Text] [Related]
5. Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells.
Lea MA; Kim H; desBORDES C
Anticancer Res; 2018 Sep; 38(9):5003-5011. PubMed ID: 30194144
[TBL] [Abstract][Full Text] [Related]
6. [Animal experimental studies on the mode of action of biguanides. 1. Studies on non hypoglycemically acting biguanide].
Losert W; Schillinger E; Kraaz W; Loge O; Jahn P
Arzneimittelforschung; 1972 Sep; 22(9):1540-52. PubMed ID: 4678618
[No Abstract] [Full Text] [Related]
7. Insulin and longevity: antidiabetic biguanides as geroprotectors.
Anisimov VN; Semenchenko AV; Yashin AI
Biogerontology; 2003; 4(5):297-307. PubMed ID: 14618027
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of blood glucose lowering biguanide derivatives].
Mehnert H
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():137-42. PubMed ID: 4906018
[No Abstract] [Full Text] [Related]
9. [A phosphorylated biguanide: benfosformin (JAV 852). I. Hypoglycemic and antidiabetic properties].
Loiseau G; Millischer R; Berthe G; Donadieu AM; Lohier P; Marquet JP
Arzneimittelforschung; 1973 Nov; 23(11):1571-6. PubMed ID: 4801663
[No Abstract] [Full Text] [Related]
10. Antidiabetic drugs after the University Group Diabetes Program (UGDP).
Karam JH; Matin SB; Forsham PH
Annu Rev Pharmacol; 1975; 15():351-66. PubMed ID: 1096790
[No Abstract] [Full Text] [Related]
11. Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase.
Bridges HR; Sirviö VA; Agip AN; Hirst J
BMC Biol; 2016 Aug; 14():65. PubMed ID: 27506389
[TBL] [Abstract][Full Text] [Related]
12. The fate of biguanides in man.
Beckmann R
Ann N Y Acad Sci; 1968 Mar; 148(3):820-32. PubMed ID: 5241479
[No Abstract] [Full Text] [Related]
13. Biguanides. A review of history, pharmacodynamics and therapy.
Schäfer G
Diabete Metab; 1983; 9(2):148-63. PubMed ID: 6352352
[TBL] [Abstract][Full Text] [Related]
14. [CLINICAL EVALUATION OF AN ORAL ANTIDIABETIC CONSISTING OF THE ASSOCIATION OF A SULFONYLUREA AND A BIGUANIDE].
FIORIO C; CASTELLAZZI R
Minerva Med; 1964 Apr; 55():1274-7. PubMed ID: 14157217
[No Abstract] [Full Text] [Related]
15. Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells.
Vigneri R; Pezzino V; Wong KY; Goldfine ID
J Clin Endocrinol Metab; 1982 Jan; 54(1):95-100. PubMed ID: 7033271
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of intestinal calcium transport by antidiabetic biguanides.
Wróbel J; Michalska L; Nagel G
Gen Pharmacol; 1979; 10(3):269-73. PubMed ID: 467964
[No Abstract] [Full Text] [Related]
17. Selective inhibition of deactivated mitochondrial complex I by biguanides.
Matsuzaki S; Humphries KM
Biochemistry; 2015 Mar; 54(11):2011-21. PubMed ID: 25719498
[TBL] [Abstract][Full Text] [Related]
18. [Animal experimental studies on the mode of action of biguanides. 1. Studies with hypoglycemia-inducing doses of biguanide].
Losert W; Schillinger E; Kraaz W; Loge O; Jahn P
Arzneimittelforschung; 1972 Jul; 22(7):1157-69. PubMed ID: 4678123
[No Abstract] [Full Text] [Related]
19. Liver uptake of biguanides in rats.
Sogame Y; Kitamura A; Yabuki M; Komuro S
Biomed Pharmacother; 2011 Sep; 65(6):451-5. PubMed ID: 21880461
[TBL] [Abstract][Full Text] [Related]
20. Toxic nephrosis in rabbits caused by the hypoglycemic biguanide, phenformin.
LAZARUS SS; BRADSHAW M; VOLK BW
Diabetes; 1960; 9():118-25. PubMed ID: 14414807
[No Abstract] [Full Text] [Related]
[Next] [New Search]
